A detailed history of New York State Common Retirement Fund transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 67,082 shares of EWTX stock, worth $2.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,082
Previous 29,846 124.76%
Holding current value
$2.2 Million
Previous $538,000 232.71%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$15.88 - $29.5 $591,307 - $1.1 Million
37,236 Added 124.76%
67,082 $1.79 Million
Q2 2024

Jul 31, 2024

SELL
$15.08 - $21.23 $585,888 - $824,827
-38,852 Reduced 56.55%
29,846 $538,000
Q1 2024

May 07, 2024

SELL
$9.25 - $19.97 $18,453 - $39,840
-1,995 Reduced 2.82%
68,698 $1.25 Million
Q4 2023

Feb 01, 2024

BUY
$5.51 - $12.1 $147,789 - $324,546
26,822 Added 61.14%
70,693 $773,000
Q3 2023

Nov 07, 2023

BUY
$5.73 - $7.69 $174,891 - $234,714
30,522 Added 228.65%
43,871 $251,000
Q2 2023

Aug 07, 2023

SELL
$5.71 - $10.29 $199 - $360
-35 Reduced 0.26%
13,349 $103,000
Q1 2023

May 02, 2023

SELL
$6.66 - $11.33 $71,468 - $121,582
-10,731 Reduced 44.5%
13,384 $89,000
Q4 2022

Jan 30, 2023

BUY
$7.58 - $11.08 $61,322 - $89,637
8,090 Added 50.48%
24,115 $216,000
Q2 2022

Aug 04, 2022

SELL
$5.67 - $9.87 $68,884 - $119,910
-12,149 Reduced 43.12%
16,025 $128,000
Q1 2022

May 05, 2022

BUY
$9.1 - $18.97 $88,397 - $184,274
9,714 Added 52.62%
28,174 $273,000
Q4 2021

Feb 02, 2022

BUY
$14.41 - $22.41 $111,461 - $173,341
7,735 Added 72.12%
18,460 $282,000
Q3 2021

Nov 02, 2021

BUY
$14.11 - $24.1 $1,763 - $3,012
125 Added 1.18%
10,725 $178,000
Q2 2021

Aug 02, 2021

BUY
$21.33 - $30.25 $226,097 - $320,650
10,600 New
10,600 $226,000

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $2.08B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.